285 related articles for article (PubMed ID: 1518255)
1. [Myelodysplastic diseases in childhood].
Niemeyer C; Stollmann-Gibbels B; Ebell W; Gaedicke G; Creutzig U
Klin Padiatr; 1992; 204(4):190-7. PubMed ID: 1518255
[TBL] [Abstract][Full Text] [Related]
2. Myelodysplastic syndromes in childhood. Report of 21 patients from Italy and West Germany.
Creutzig U; Cantù-Rajnoldi A; Ritter J; Romitti L; Odenwald E; Conter V; Riehm H; Masera G
Am J Pediatr Hematol Oncol; 1987; 9(4):324-30. PubMed ID: 3439582
[TBL] [Abstract][Full Text] [Related]
3. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia.
Estey EH; Keating MJ; Dixon DO; Trujillo JM; McCredie KB; Freireich EJ
Hematol Pathol; 1987; 1(4):203-8. PubMed ID: 3504436
[TBL] [Abstract][Full Text] [Related]
4. Myelodysplastic syndromes: the pediatric point of view.
Locatelli F; Zecca M; Pession A; Maserati E; De Stefano P; Severi F
Haematologica; 1995; 80(3):268-79. PubMed ID: 7672722
[TBL] [Abstract][Full Text] [Related]
5. Experience in pediatric myelodysplastic syndromes.
Gadner H; Haas OA
Hematol Oncol Clin North Am; 1992 Jun; 6(3):655-72. PubMed ID: 1613011
[TBL] [Abstract][Full Text] [Related]
6. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
7. [Myelodysplastic syndrome].
Urabe A
Gan To Kagaku Ryoho; 2005 Mar; 32(3):287-91. PubMed ID: 15791810
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of myelodysplastic syndromes].
Aul C; Heyll A; Gattermann N; Schneider W
Dtsch Med Wochenschr; 1987 Feb; 112(8):309-13. PubMed ID: 3469067
[No Abstract] [Full Text] [Related]
9. Myelodysplastic and myeloproliferative disorders in children.
Hasle H
Curr Opin Pediatr; 2007 Feb; 19(1):1-8. PubMed ID: 17224655
[TBL] [Abstract][Full Text] [Related]
10. Intensive chemotherapy and bone marrow transplantation for myelodysplastic syndromes.
Löffler H; Schmitz N; Gassmann W
Hematol Oncol Clin North Am; 1992 Jun; 6(3):619-31. PubMed ID: 1613010
[TBL] [Abstract][Full Text] [Related]
11. Myelodysplastic syndromes clinical practice guidelines in oncology.
Greenberg PL; Baer MR; Bennett JM; Bloomfield CD; De Castro CM; Deeg HJ; Devetten MP; Emanuel PD; Erba HP; Estey E; Foran J; Gore SD; Millenson M; Navarro WH; Nimer SD; O'Donnell MR; Saba HI; Spiers K; Stone RM; Tallman MS
J Natl Compr Canc Netw; 2006 Jan; 4(1):58-77. PubMed ID: 16403405
[No Abstract] [Full Text] [Related]
12. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
Hall J; Foucar K
Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
[TBL] [Abstract][Full Text] [Related]
13. [Differentiating agents in myelodysplastic syndromes. Analysis of personal cases].
Olivieri A; Leoni P; Ciniero L; Offidani M; Montillo M; Ziarati H; Centurioni R; Brianzoni F; Salvi A; Danieli G
Recenti Prog Med; 1993 Mar; 84(3):168-76. PubMed ID: 8465097
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic possibilities in the treatment of the myelodysplasia syndrome].
Bozóky G; Biliczki F
Orv Hetil; 1991 May; 132(19):1011-5. PubMed ID: 2027674
[TBL] [Abstract][Full Text] [Related]
15. Treatment of pediatric myelodysplastic syndromes and juvenile myelomonocytic leukemia: the Brazilian experience in the past decade.
Valera ET; Latorre Mdo R; Mendes WL; Seber A; Lee ML; de Paula MJ; Loggetto SR; Velloso E; Niero-Melo L; Lopes LF;
Leuk Res; 2004 Sep; 28(9):933-9. PubMed ID: 15234570
[TBL] [Abstract][Full Text] [Related]
16. Internal tandem duplication of fms-like tyrosine kinase 3 is associated with poor outcome in patients with myelodysplastic syndrome.
Shih LY; Lin TL; Wang PN; Wu JH; Dunn P; Kuo MC; Huang CF
Cancer; 2004 Sep; 101(5):989-98. PubMed ID: 15329908
[TBL] [Abstract][Full Text] [Related]
17. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
[TBL] [Abstract][Full Text] [Related]
19. Oncogene mutation and prognosis in the myelodysplastic syndromes.
Padua RA; West RR
Br J Haematol; 2000 Dec; 111(3):873-4. PubMed ID: 11122149
[TBL] [Abstract][Full Text] [Related]
20. Successful Allogenic Haematopoietic Stem Cell Transplantation in a Boy with Hemophilia A and MDS-RAEB.
Reimann C; van Buiren M; Schelling J; Halimeh S; Niehues T; Strahm B; Zieger B
Klin Padiatr; 2016 Nov; 228(6-07):336-338. PubMed ID: 27571289
[No Abstract] [Full Text] [Related]
[Next] [New Search]
